Johnson & Johnson's Ortho Clinical hived off as separate entity

Ortho Clinical Diagnostics (Ortho), a business unit of Johnson & Johnson India, is being hived off into a separate company, as part of a global restructuring. Ortho, which manufactures clinical diagnostics for laboratories and blood banks, was acquired from J&J by theCarlyle group in a $6 billion deal globally in June 2014 Stock Market Trading Tips

The transition is taking place in India with effect from October 26 after all regulatory approvals, a company official told TOI. The turnover of Ortho Clinical Diagnostics is estimated to be around Rs 220 crore. 

Ortho Clinical Diagnostics serves the global transfusion medicine community with donor screening and blood typing products to help ensure that patients receives blood that is safe, the right type and right unit Himanshu Tiwari Astrologer Blog

"As an independent organization, our focus continues to be on our commitment to the Indian healthcare industry, and its providers, to better serve the patient. We intend to further invest in research and development to create products that will assist in decision making and thus ensure that patients receive the requisite diagnosis and treatment," Ortho India's managing director Anand Pande said.